AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?

IF 4.7 2区 医学 Q1 ONCOLOGY Annual Review of Cancer Biology-Series Pub Date : 2023-01-17 DOI:10.1146/annurev-cancerbio-061521-092038
D. Cifci, G. P. Veldhuizen, S. Foersch, Jakob Nikolas Kather
{"title":"AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?","authors":"D. Cifci, G. P. Veldhuizen, S. Foersch, Jakob Nikolas Kather","doi":"10.1146/annurev-cancerbio-061521-092038","DOIUrl":null,"url":null,"abstract":"Histopathology plays a fundamental role in the diagnosis and subtyping of solid tumors and has become a cornerstone of modern precision oncology. Histopathological evaluation is typically performed manually by expert pathologists due to the complexity of visual data. However, in the last ten years, new artificial intelligence (AI) methods have made it possible to train computers to perform visual tasks with high performance, reaching similar levels as experts in some applications. In cancer histopathology, these AI tools could help automate repetitive tasks, making more efficient use of pathologists’ time. In research studies, AI methods have been shown to have an astounding ability to predict genetic alterations and identify prognostic and predictive biomarkers directly from routine tissue slides. Here, we give an overview of these recent applications of AI in computational pathology, focusing on new tools for cancer research that could be pivotal in identifying clinical biomarkers for better treatment decisions. Expected final online publication date for the Annual Review of Cancer Biology, Volume 7 is April 2023. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.","PeriodicalId":54233,"journal":{"name":"Annual Review of Cancer Biology-Series","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annual Review of Cancer Biology-Series","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1146/annurev-cancerbio-061521-092038","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 5

Abstract

Histopathology plays a fundamental role in the diagnosis and subtyping of solid tumors and has become a cornerstone of modern precision oncology. Histopathological evaluation is typically performed manually by expert pathologists due to the complexity of visual data. However, in the last ten years, new artificial intelligence (AI) methods have made it possible to train computers to perform visual tasks with high performance, reaching similar levels as experts in some applications. In cancer histopathology, these AI tools could help automate repetitive tasks, making more efficient use of pathologists’ time. In research studies, AI methods have been shown to have an astounding ability to predict genetic alterations and identify prognostic and predictive biomarkers directly from routine tissue slides. Here, we give an overview of these recent applications of AI in computational pathology, focusing on new tools for cancer research that could be pivotal in identifying clinical biomarkers for better treatment decisions. Expected final online publication date for the Annual Review of Cancer Biology, Volume 7 is April 2023. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工智能在癌症计算病理学中的应用:改善诊断工作流程和临床结果?
组织病理学在实体瘤的诊断和分型中起着重要作用,已成为现代精确肿瘤学的基石。由于视觉数据的复杂性,组织病理学评估通常由专业病理学家手动进行。然而,在过去的十年里,新的人工智能(AI)方法使训练计算机执行高性能视觉任务成为可能,在某些应用中达到了与专家相似的水平。在癌症组织病理学中,这些人工智能工具可以帮助自动化重复任务,更有效地利用病理学家的时间。在研究中,人工智能方法已被证明具有惊人的能力,可以直接从常规组织切片中预测基因改变并识别预后和预测性生物标志物。在这里,我们概述了人工智能在计算病理学中的这些最新应用,重点关注癌症研究的新工具,这些工具可能在识别临床生物标志物以做出更好的治疗决策方面发挥关键作用。《癌症生物学年度评论》第7卷预计最终在线出版日期为2023年4月。请参阅http://www.annualreviews.org/page/journal/pubdates用于修订估算。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
14.50
自引率
1.30%
发文量
13
期刊介绍: The Annual Review of Cancer Biology offers comprehensive reviews on various topics within cancer research, covering pivotal and emerging areas in the field. As our understanding of cancer's fundamental mechanisms deepens and more findings transition into targeted clinical treatments, the journal is structured around three main themes: Cancer Cell Biology, Tumorigenesis and Cancer Progression, and Translational Cancer Science. The current volume of this journal has transitioned from gated to open access through Annual Reviews' Subscribe to Open program, ensuring all articles are published under a CC BY license.
期刊最新文献
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies On the Biology and Therapeutic Modulation of Macrophages and Dendritic Cells in Cancer Next-Generation Estrogen Receptor–Targeted Therapeutics Engineering the Immune Microenvironment into Organoid Models The Effects of Clonal Heterogeneity on Cancer Immunosurveillance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1